TOBI owner Contact Information online
from Novartis AG
TOBI
The mark consists of the word "TOBI" below two wavy lines of different lengths; the color gray is intended to show shading or contrast only.
US serial number:85145153
Application filling date:Oct. 05, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Feb. 25, 2014
Publication date:Feb. 22, 2011
Standard character claim:No
Mark drawing type:3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Goods and services:For: Pharmaceutical preparations for the treatment of disorders of the respiratory system
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(a)
First Use: Apr. 30, 2013
Use in Commerce: Apr. 30
Services:Pharmaceutical preparations for the treatment of disorders of the respiratory system
Current owner owner name:Novartis AG
Current owner owner address:CH 4002
Basel
SWITZERLAND
Current owner legal entity type:CORPORATION
Current owner state or country:SWITZERLAND
Attorney name:Maury M. Tepper, III
Attorney email:mtepper@teiplaw.com
Attorney email authorized:Yes
Correspondent name address:MAURY M. TEPPER, III
TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH,
NORTH CAROLINA
UNITED STATES
27609-7321
Correspondent phone:919-861-8903
Correspondent email:mtepper@teiplaw.com
Correspondent fax:919-861-8913
Correspondent email authorized:Yes
Domestic representative name:Novartis Pharmaceuticals Corporation
Domestic representative phone:919-861-8903
Domestic representative fax TOBI:919-861-8913
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (150) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) SANOFI (47) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Feb. 22, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Oct. 05, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011
